Dr. Gabrielson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Ave
Baltimore, MD 21224Phone+1 410-955-2660Fax+1 410-550-0101
Education & Training
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1983 - 1985
- University of ColoradoResidency, Pathology-Anatomic and Clinical, 1978 - 1982
- Northwestern University The Feinberg School of MedicineClass of 1978
Certifications & Licensure
- MD State Medical License 1984 - 2026
- DC State Medical License 2023 - 2024
- FL State Medical License 2013 - 2015
- WY State Medical License 1982 - 1985
- IL State Medical License 1982 - 1984
- CO State Medical License 1980 - 1983
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Clinical Trials
- Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A) Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 362 citationsSmall Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC TumorsAnju Singh, Sreedhar Venkannagari, Kyu H. Oh, Ya Qin Zhang, Jason M. Rohde
ACS Chemical Biology. 2016-10-17 - 202 citationsLong interspersed element-1 protein expression is a hallmark of many human cancersNemanja Rodić, Reema Sharma, Rajni Sharma, John G. Zampella, Lixin Dai
The American Journal of Pathology. 2014-05-01 - 872 citationsPromoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian TumorsManel Esteller, Jose Maria Silva, Gemma Domínguez, Félix Bonilla, Xavier Matias-Guiu
Journal of the National Cancer Institute. 2000-04-05
Journal Articles
- Original Contribution Detection of RAS and RAS-Associated Alterations in Primary Lung Adenocarcinomas. A Correlation Between Molecular Findings and Tumor Characteristics☆Irfan Shaukat, Gang Zheng, Edward Gabrielson, Frederic Askin, Qing Kay Li, ScienceDirect
- Chemotherapy Induces Enrichment of CD47+/CD73+/PDL1+ Immune Evasive Triple-Negative Breast Cancer CellsEdward Gabrielson, Gregg L Semenza, Proceedings of the National Academy of Sciences
Press Mentions
- Johns Hopkins Researchers Launch Interdisciplinary Effort for Breast CancerNovember 2nd, 2017
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/edward-gabrielson
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: